(Q40994528)

25 September 2017

Chronic rejection and chronic cyclosporin toxicity in renal allografts (English)

1 reference

25 September 2017

Pascual M

1

1 reference

25 September 2017

Swinford RD

2

1 reference

25 September 2017

Ingelfinger JR

3

1 reference

25 September 2017

Williams WW

4

1 reference

25 September 2017

Cosimi AB

5

1 reference

25 September 2017

Tolkoff-Rubin N

6

1 reference

25 September 2017

1 November 1998

1 reference

25 September 2017

1 reference

25 September 2017

19

1 reference

25 September 2017

11

1 reference

25 September 2017

514-519

1 reference

OBLITERATIVE VASCULAR CHANGES IN FOUR HUMAN KIDNEY HOMOTRANSPLANTS.

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Risk factors for chronic rejection in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Determinants of chronic renal allograft rejection in cyclosporine-treated recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Long-term complications after transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

The hyperfiltration theory: a paradigm shift in nephrology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Chronic transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Chronic renal transplant loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

1 reference

7 January 2021

TGF-beta in kidney fibrosis: a target for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

TGF-beta and the endothelium during immune injury

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Platelet-derived growth factor: a key regulator of connective tissue cells in embryogenesis and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

The plasminogen activator/plasmin system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Induction of plasminogen activator inhibitor type 1 in murine lupus-like glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Altered expression of transforming growth factor-beta S in chronic renal rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Immunolocalization of FGF-1 and receptors in human renal allograft vasculopathy associated with chronic rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Transplantation tolerance prevents cardiac allograft vasculopathy in major histocompatibility complex class I-disparate miniature swine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Differential regulation of transforming growth factor beta and interleukin 2 genes in human T cells: demonstration by usage of novel competitor DNA constructs in the quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Mechanism of fibrosis in experimental tacrolimus nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Immunosuppressants: cellular and molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

Sirolimus: a new agent for clinical renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901324-3

7 January 2021

10.1016/S0167-5699(98)01324-3

Identifiers

DOI

1 reference

25 September 2017

1 reference